Literature DB >> 2973464

Multiple abnormal beta-hexosaminidase alpha chain mRNAs in a compound-heterozygous Ashkenazi Jewish patient with Tay-Sachs disease.

K Ohno1, K Suzuki.   

Abstract

Abnormal beta-hexosaminidase alpha chain cDNA clones were isolated from fibroblasts of an Ashkenazi Jewish patient with Tay-Sachs disease. Four abnormal cDNA clones were sequenced in their entirety. We showed previously that three of these mRNAs retained intron 12 with a mutation from G to C at the 5' donor site and that the patient was heterozygous with respect to this splicing defect (Ohno, K., and Suzuki, K., (1988) Biochem. Biophys. Res. Commun. 153, 463-469). One clone retained, in addition to intron 12, intron 13, which was truncated and polyadenylated due to a polyadenylation signal within intron 13. The fourth clone did not contain intron 12 and was missing exon 12. Some of these abnormal mRNAs were also missing one or more of upstream exons. The regions of exon 12-intron 12 and of upstream exons were evaluated in a total of 30 clones, including those completely sequenced, by restriction mapping and Southern analysis with appropriate probes. Of the 25 cDNA clones that included the exon 12-intron 12 region, 11 contained the exon 12-intron 12 sequence with the junctional transversion, and 11 were missing both exon 12 and intron 12. Among the 12 clones that included the region of exon 3-exon 9, 7 were missing one or more of upstream exons. Three clones gave results expected of normal cDNA in the region of exons 12 and 13. One of the three, furthermore, was 3.6-kilobases long and contained the completely normal beta-hexosaminidase alpha chain mRNA sequence on the 3' side and an abnormal 1.7-kilobase segment at the 5' end. These findings suggest that the splicing defect results in either retention of intron 12 or skipping of exon 12 in approximately equal proportions and that remote upstream exons are also frequently excised out. The three clones that were normal in the exon 12-intron 12 region could have derived from the other yet-to-be-characterized mutant allele. However, we were unable to obtain firm evidence that the abnormal upstream sequence is directly related to Tay-Sachs disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2973464

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Effect of 5' splice site mutations on splicing of the preceding intron.

Authors:  M Talerico; S M Berget
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

2.  In vivo recognition of a vertebrate mini-exon as an exon-intron-exon unit.

Authors:  D A Sterner; S M Berget
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

3.  Frequency of three Hex A mutant alleles among Jewish and non-Jewish carriers identified in a Tay-Sachs screening program.

Authors:  B H Paw; P T Tieu; M M Kaback; J Lim; E F Neufeld
Journal:  Am J Hum Genet       Date:  1990-10       Impact factor: 11.025

4.  Insertion in the mRNA of a metachromatic leukodystrophy patient with sphingolipid activator protein-1 deficiency.

Authors:  X L Zhang; M A Rafi; G DeGala; D A Wenger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

5.  Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group.

Authors:  G Millat; K Chikh; S Naureckiene; D E Sleat; A H Fensom; K Higaki; M Elleder; P Lobel; M T Vanier
Journal:  Am J Hum Genet       Date:  2001-09-20       Impact factor: 11.025

6.  Intron definition in splicing of small Drosophila introns.

Authors:  M Talerico; S M Berget
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

7.  Beta-hexosaminidase splice site mutation has a high frequency among non-Jewish Tay-Sachs disease carriers from the British Isles.

Authors:  E C Landels; P M Green; I H Ellis; A H Fensom; M Bobrow
Journal:  J Med Genet       Date:  1992-08       Impact factor: 6.318

8.  Bioinformatic primer for clinical and translational science.

Authors:  Randolph S Faustino; Anca Chiriac; Andre Terzic
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

9.  Molecular characterization of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: identification of a lys329 to glu mutation in the MCAD gene, and expression of inactive mutant enzyme protein in E. coli.

Authors:  N Gregersen; B S Andresen; P Bross; V Winter; N Rüdiger; S Engst; E Christensen; D Kelly; A W Strauss; S Kølvraa
Journal:  Hum Genet       Date:  1991-04       Impact factor: 4.132

10.  Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene.

Authors:  H Steingrimsdottir; G Rowley; G Dorado; J Cole; A R Lehmann
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.